Gene · 4209
Papers1,497
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,497
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Development of Novel Treatment Strategies for Rhabdomyosarcoma. | Cancers (Basel) | 2026 | 41749943 | PubTator, text mining | PubMed |
| Exploring immune-inflammatory cross-talk in atherosclerosis using AI-enhanced multi-omics approaches. | Clin Exp Med | 2026 | 41739231 | PubTator, text mining | PubMed |
| A review of treatment strategies for elderly patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia. | Transl Oncol | 2026 | 41690286 | PubTator, text mining | PubMed |
| [Retracted] miR‑218 suppresses cardiac myxoma proliferation by targeting myocyte enhancer factor 2D. | Oncol Rep | 2026 | 41685603 | PubTator, text mining | PubMed |
| Stage-specific transcriptional atlas of goose satellite cells uncovers molecular dynamics driving embryonic skeletal muscle development. | Poult Sci | 2026 | 41650636 | PubTator, text mining | PubMed |
| T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy. | J Cell Mol Med | 2026 | 41645702 | PubTator, text mining | PubMed |
| Hypercapnia Effects on Lung Function. | Compr Physiol | 2026 | 41578665 | PubTator, text mining | PubMed |
| Multi-scale transcriptomics analysis reveals MHC suppression in MEF2D fusion positive B-cell acute lymphoblastic leukemia. | Biochem Biophys Res Commun | 2026 | 41547299 | PubTator, text mining | PubMed |
| Dysregulation of miR-642a-5p is involved in the regulation of pancreatic β-cell function via Mef2d. | Endocr J | 2026 | 41500569 | PubTator, text mining | PubMed |
| Polygonatum kingianum alleviates diabetic inflammation via the Mef2d/Rufy4-autophagy axis to drive macrophage M2 polarisation. | Arch Physiol Biochem | 2026 | 41493861 | PubTator, text mining | PubMed |
| RNF39 promotes colorectal cancer progression by driving RINT1 degradation and suppressing ER stress-induced apoptosis. | Clin Transl Med | 2026 | 41457280 | PubTator, text mining | PubMed |
| Hsa_circ_0013729 Promotes Gastric Cancer Progression by Regulating MEF2D in ceRNA- and RBP- Dependent Manners. | Biochem Genet | 2026 | 40767994 | PubTator, text mining | PubMed |
| Low EVI1 expression at diagnosis identifies a high-risk subgroup in adult Ph-negative B-cell acute lymphoblastic leukemia. | Front Med (Lausanne) | 2025 | 41608431 | PubTator, text mining | PubMed |
| Commentary: Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC. | Front Pharmacol | 2025 | 41158124 | PubTator, text mining | PubMed |
| Genomic discovery of EF-24 targets unveils antitumorigenic mechanisms in leukemia cells. | PLoS One | 2025 | 40986633 | PubTator, text mining | PubMed |
| CABIN1 peptide effectively targets MEF2D-fusion protein in B-cell precursor acute lymphoblastic leukemia. | Signal Transduct Target Ther | 2025 | 40947444 | PubTator, text mining | PubMed |
| Exploring the Association of Migraine Susceptibility SNPs With the Risk of Chronic Migraine. | Eur J Pain | 2025 | 40910422 | PubTator, text mining | PubMed |
| Uterine Myxoid Mesenchymal Tumor With a Novel SS18::VEZF1 Gene Fusion, Lacking Worrisome Histological Features. | Genes Chromosomes Cancer | 2025 | 40878061 | PubTator, text mining | PubMed |
| The roles of non-coding RNAs (ncRNAs) in the function of leukemic stem cells (LSCs): a comprehensive review. | Discov Oncol | 2025 | 40853607 | PubTator, text mining | PubMed |
| Unveiling migraine subtype heterogeneity and risk loci: integrated genome-wide association study and single-cell transcriptomics discovery. | J Headache Pain | 2025 | 40826382 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4209/papers?page=2